<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">61174</article-id><article-id pub-id-type="doi">10.7554/eLife.61174</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Biochemistry and Chemical Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Medicine</subject></subj-group></article-categories><title-group><article-title>The half-life of the bone-derived hormone osteocalcin is regulated through <italic>O</italic>-glycosylation in mice, but not in humans</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-198914"><name><surname>Al Rifai</surname><given-names>Omar</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-5"/><xref ref-type="other" rid="par-6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-198916"><name><surname>Julien</surname><given-names>Catherine</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-198915"><name><surname>Lacombe</surname><given-names>Julie</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-198918"><name><surname>Faubert</surname><given-names>Denis</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-198917"><name><surname>Lira-Navarrete</surname><given-names>Erandi</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-198913"><name><surname>Narimatsu</surname><given-names>Yoshiki</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-36895"><name><surname>Clausen</surname><given-names>Henrik</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="par-4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-168319"><name><surname>Ferron</surname><given-names>Mathieu</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-5858-2686</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Molecular Physiology</institution>, <institution>IRCM</institution>, <addr-line><named-content content-type="city">Montreal</named-content></addr-line>, <country>Canada</country></aff><aff id="aff2"><institution content-type="dept">Proteomics Discovery Platform</institution>, <institution>IRCM</institution>, <addr-line><named-content content-type="city">Montreal</named-content></addr-line>, <country>Canada</country></aff><aff id="aff3"><institution content-type="dept">Copenhagen Center for Glycomics, Departments of Cellular and Molecular Medicine and School of Dentistry, Faculty of Health Sciences</institution>, <institution>University of Copenhagen</institution>, <addr-line><named-content content-type="city">Copenhagen</named-content></addr-line>, <country>Denmark</country></aff><aff id="aff4"><institution content-type="dept">Department of Cellular and Molecular Medicine</institution>, <institution>University of Copenhagen</institution>, <addr-line><named-content content-type="city">Copenhagen</named-content></addr-line>, <country>Denmark</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-73636"><name><surname>Zaidi</surname><given-names>Mone</given-names></name><role>Reviewing editor</role><aff><institution>Icahn School of Medicine at Mount Sinai</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>mathieu.ferron@ircm.qc.ca</email> (MF);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>07</day><month>12</month><year>2020</year></pub-date><volume>9</volume><elocation-id>e61174</elocation-id><history><date date-type="received"><day>16</day><month>07</month><year>2020</year></date><date date-type="accepted"><day>06</day><month>12</month><year>2020</year></date></history><permissions><copyright-statement>© 2020, Al Rifai et al</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Al Rifai et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-61174-v1.pdf"/><abstract><p>Osteocalcin (OCN) is an osteoblast-derived hormone with pleiotropic physiological functions. Like many peptide hormones, OCN is subjected to post-translational modifications (PTMs) which control its activity. Here, we uncover <italic>O</italic>-glycosylation as a novel PTM present on mouse OCN and occurring on a single serine (S8) independently of its carboxylation and endoproteolysis, two other PTMs regulating this hormone. We also show that <italic>O</italic>-glycosylation increases OCN half-life in plasma ex vivo and in the circulation in vivo. Remarkably, in human OCN (hOCN), the residue corresponding to S8 is a tyrosine (Y12), which is not <italic>O-</italic>glycosylated. Yet, the Y12S mutation is sufficient to <italic>O</italic>-glycosylate hOCN and to increase its half-life in plasma compared to wildtype hOCN. These findings reveal an important species difference in OCN regulation, which may explain why serum concentrations of OCN are higher in mouse than in human.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000024</institution-id><institution>Canadian Institutes of Health Research</institution></institution-wrap></funding-source><award-id>Operation fund,MOP-133652</award-id><principal-award-recipient><name><surname>Ferron</surname><given-names>Mathieu</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000024</institution-id><institution>Canadian Institutes of Health Research</institution></institution-wrap></funding-source><award-id>Project Operating fund,PJT-159534</award-id><principal-award-recipient><name><surname>Ferron</surname><given-names>Mathieu</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000038</institution-id><institution>Natural Sciences and Engineering Research Council of Canada</institution></institution-wrap></funding-source><award-id>Discovery grant,RGPIN-2016-05213</award-id><principal-award-recipient><name><surname>Ferron</surname><given-names>Mathieu</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001732</institution-id><institution>Danmarks Grundforskningsfond</institution></institution-wrap></funding-source><award-id>DNRF107</award-id><principal-award-recipient><name><surname>Clausen</surname><given-names>Henrik</given-names></name></principal-award-recipient></award-group><award-group id="par-5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000156</institution-id><institution>Fonds de Recherche du Québec - Santé</institution></institution-wrap></funding-source><award-id>Doctoral scholarship</award-id><principal-award-recipient><name><surname>Al Rifai</surname><given-names>Omar</given-names></name></principal-award-recipient></award-group><award-group id="par-6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100005241</institution-id><institution>Institut de Recherche Clinique De Montréal</institution></institution-wrap></funding-source><award-id>Doctoral scholarship</award-id><principal-award-recipient><name><surname>Al Rifai</surname><given-names>Omar</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: All animal use complied with the guidelines of the Canadian Committee for Animal Protection and was approved by IRCM Animal Care Committee (protocol # 2016-14 MF).</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>All the numerical data and the original western blots are available in the source data Excel file submitted with the manuscript. The raw proteomics data have been uploaded to a public server.</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Al Rifai O</collab><collab>Julien C</collab><collab>Lacombe J</collab><collab>Faubert D</collab><collab>Lira-Navarrete E</collab><collab>Narimatsu YJL</collab><collab>Clausen H</collab><collab>Ferron M</collab></person-group><year iso-8601-date="2020">2020</year><source>MS raw files for The half-life of the bone-derived hormone osteocalcin is regulated through O-glycosylation in mice, but not in humans</source><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.6084/m9.figshare.13259891.v1">https://doi.org/10.6084/m9.figshare.13259891.v1</ext-link><comment>Figshare, https://doi.org/10.6084/m9.figshare.13259891.v1</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-61174-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>